Individualized pharmaceutical care in one patient with aplastic anemia / 中国药学杂志

ABSTRACT

OBJECTIVE: To explore the application of pharmacogenomics, drug interaction analysis, and therapeutic drug monitoring in the pharmaceutical care of patients with aplastic anemia. METHODS: Clinical pharmacists provided pharmaceutical care to one patient with aplastic anemia including estimation of cyclosporine (CsA) dose using pharmacogenomic test result, increasing the blood CsA concentrations by taking advantage of drug interactions, blood concentration monitoring, medication education and so on. RESULTS: Clinical pharmacists made rational suggestions, and satisfactory therapeutic effect was finally achieved. CONCLUSION: Clinical pharmacists can play an active role in clinical treatment by joining clinical teams and providing individualized pharmaceutical care.